Tofa may be option for pts w/ refractory skin predominant dermatomyositis. Abs 1887 #ACR22 @RheumNow https://t.co/heJ1kZeuPT https://t.co/CqK0dL7DQK
Links:
Determining the Long-term Safety and Efficacy of JAK Inhibitors in the Treatmen…
http://ow.ly/L3lm50LAbfU
14-11-2022